Dorsolateral Prefrontal Cortex: A Possible Target for Modulating Dyskinesias in Parkinson's Disease by Repetitive Transcranial Magnetic Stimulation
2008

Modulating Dyskinesias in Parkinson's Disease with rTMS

Sample size: 6 publication Evidence: low

Author Information

Author(s): I. Rektorova, S. Sedlackova, S. Telecka, A. Hlubocky, I. Rektor

Primary Institution: Masaryk University, Saint Anne's Hospital, Brno, Czech Republic

Hypothesis

Can repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex reduce L-dopa-induced dyskinesias in advanced Parkinson's disease patients?

Conclusion

The study suggests that rTMS over the left dorsolateral prefrontal cortex may reduce the frequency and intensity of dyskinesias in advanced Parkinson's disease patients, although the results did not reach statistical significance.

Supporting Evidence

  • Patients reported a subjective improvement in dyskinesias after rTMS treatment.
  • Significant decrease in the amplitude of motor evoked potentials was observed after rTMS over the left DLPFC.
  • The study included a randomized, controlled design with assessments before and after treatment.

Takeaway

Doctors used a special technique called rTMS to try to help people with Parkinson's disease who have trouble moving because of their medicine. Some people felt better, but the results weren't strong enough to be sure it worked.

Methodology

The study involved 6 advanced Parkinson's disease patients receiving 5 sessions of rTMS at 10 Hz over the left dorsolateral prefrontal cortex or the primary motor cortex, with assessments using the Unified Parkinson's Disease Rating Scale.

Potential Biases

The lack of a placebo control for the DLPFC stimulation raises concerns about potential placebo effects.

Limitations

The study was stopped prematurely due to patient withdrawals, and the assessment of dyskinesias was not the primary outcome.

Participant Demographics

5 men and 1 woman, mean age 67.3 years, with advanced Parkinson's disease and a Hoehn-Yahr stage between 2.5 and 4.

Statistical Information

P-Value

0.06

Statistical Significance

p=0.06

Digital Object Identifier (DOI)

10.1155/2008/372125

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication